Condition
Mass Casualty Incident
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Hypodermoclysis Via Recombinant Hyaluronidasefacilitated Subcutaneous Infusion
Research Leaders
7 sponsors active, led by Baxter Healthcare Corporation
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Phase 3 (1)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Hypodermoclysis Via Recombinant Hyaluronidasefacilitated Subcutaneous Infusion1
- Virtual Reality1
Active Sponsors
- Baxter Healthcare Corporation1
- CrashCourse AB1
- Sophiahemmet University1
- Laerdal Medical Foundation1
- Ambulance Service in Stockholm, Sweden (AISAB)1
Top Investigators
Sophiahemmet University
Massachusetts General Hospital
Related Conditions
- Dehydration1
- Training1
- Triage1
- Learning1